Psychiatry Research: Neuroimaging
Volume 173, Issue 1 , Pages 31-38, 15 July 2009

Changes in prefrontal and amygdala activity during olanzapine treatment in schizophrenia

  • Giuseppe Blasi

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
  • ,
  • Teresa Popolizio

      Affiliations

    • Department of Neuroradiology, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Italy
  • ,
  • Paolo Taurisano

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
  • ,
  • Grazia Caforio

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
  • ,
  • Raffaella Romano

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
  • ,
  • Annabella Di Giorgio

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
  • ,
  • Fabio Sambataro

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
    • Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA
  • ,
  • Valeria Rubino

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
  • ,
  • Valeria Latorre

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
  • ,
  • Luciana Lo Bianco

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
  • ,
  • Leonardo Fazio

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
  • ,
  • Marcello Nardini

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
  • ,
  • Daniel R. Weinberger

      Affiliations

    • Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA
  • ,
  • Alessandro Bertolino

      Affiliations

    • Psychiatric Neuroscience Group, Section on Mental Disorders, Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy
    • Department of Neuroradiology, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Italy
    • Corresponding Author InformationCorresponding author. Dipartimento di Scienze Neurologiche e Psichiatriche, Università degli Studi di Bari, Piazza Giulio Cesare, 9, 70124 Bari, Italy. Tel.: +39 080 5478572; fax: +39 080 5593204.

Received 29 February 2008; received in revised form 29 July 2008; accepted 8 September 2008.

Abstract 

Earlier imaging studies in schizophrenia have reported abnormal amygdala and prefrontal cortex activity during emotion processing. We investigated with functional magnetic resonance imaging (fMRI) during emotion processing changes in activity of the amygdala and of prefrontal cortex in patients with schizophrenia during 8 weeks of olanzapine treatment. Twelve previously drug-free/naive patients with schizophrenia were treated with olanzapine for 8 weeks and underwent two fMRI scans after 4 and 8 weeks of treatment during implicit and explicit emotional processing. Twelve healthy subjects were also scanned twice to control for potential repetition effects. Results showed a diagnosis by time interaction in left amygdala and a diagnosis by time by task interaction in right ventrolateral prefrontal cortex. In particular, activity in left amygdala was greater in patients than in controls at the first scan during both explicit and implicit processing, while it was lower in patients at the second relative to the first scan. Furthermore, during implicit processing, right ventrolateral prefrontal cortex activity was lower in patients than controls at the first scan, while it was greater in patients at the second relative to the first scan. These results suggest that longitudinal treatment with olanzapine may be associated with specific changes in activity of the amygdala and prefrontal cortex during emotional processing in schizophrenia.

Keywords: Amygdala, Antipsychotic drugs, Emotions, Functional magnetic resonance imaging, Schizophrenia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0925-4927(08)00143-1

doi:10.1016/j.pscychresns.2008.09.001

Psychiatry Research: Neuroimaging
Volume 173, Issue 1 , Pages 31-38, 15 July 2009